Chenghui Yan

2.9k total citations
166 papers, 2.3k citations indexed

About

Chenghui Yan is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Chenghui Yan has authored 166 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Molecular Biology, 43 papers in Cardiology and Cardiovascular Medicine and 42 papers in Immunology. Recurrent topics in Chenghui Yan's work include Atherosclerosis and Cardiovascular Diseases (18 papers), Angiogenesis and VEGF in Cancer (14 papers) and Cardiac Fibrosis and Remodeling (14 papers). Chenghui Yan is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (18 papers), Angiogenesis and VEGF in Cancer (14 papers) and Cardiac Fibrosis and Remodeling (14 papers). Chenghui Yan collaborates with scholars based in China, Australia and United States. Chenghui Yan's co-authors include Yaling Han, Xiaoxiang Tian, Jian Kang, James Darnell, Robert H. Costa, T A Van Dyke, Dan Liu, Haixu Song, Xiaolin Zhang and Jie Deng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Nature Communications.

In The Last Decade

Chenghui Yan

159 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chenghui Yan China 27 1.2k 403 363 360 335 166 2.3k
Weibin Cai China 29 1.2k 1.0× 429 1.1× 207 0.6× 223 0.6× 302 0.9× 78 2.1k
Françoise Bono France 29 1.3k 1.1× 404 1.0× 341 0.9× 398 1.1× 133 0.4× 65 2.7k
Mary M. Kavurma Australia 30 1.5k 1.2× 413 1.0× 200 0.6× 751 2.1× 285 0.9× 60 2.4k
Patrizia Nigro Italy 23 1.5k 1.3× 274 0.7× 426 1.2× 461 1.3× 142 0.4× 44 2.4k
Sasha A. Singh United States 24 1.4k 1.2× 235 0.6× 406 1.1× 357 1.0× 176 0.5× 83 2.5k
Lin Xu United States 29 1.7k 1.4× 295 0.7× 472 1.3× 410 1.1× 201 0.6× 143 2.6k
Koichiro Mihara Canada 25 1.2k 1.0× 313 0.8× 321 0.9× 332 0.9× 189 0.6× 69 2.7k
Eva Bengtsson Sweden 28 785 0.7× 364 0.9× 326 0.9× 1.0k 2.8× 414 1.2× 87 2.5k
Philipp Stawowy Germany 28 825 0.7× 401 1.0× 743 2.0× 269 0.7× 160 0.5× 90 2.3k
Yan Ru Su United States 27 937 0.8× 236 0.6× 242 0.7× 253 0.7× 130 0.4× 65 1.8k

Countries citing papers authored by Chenghui Yan

Since Specialization
Citations

This map shows the geographic impact of Chenghui Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenghui Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenghui Yan more than expected).

Fields of papers citing papers by Chenghui Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenghui Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenghui Yan. The network helps show where Chenghui Yan may publish in the future.

Co-authorship network of co-authors of Chenghui Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Chenghui Yan. A scholar is included among the top collaborators of Chenghui Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenghui Yan. Chenghui Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xiaolin, Miaohan Qiu, Ming‐Huei Cheng, et al.. (2025). Kynurenic Acid Is a Predictive Prognostic Metabolic Marker in ST‐Elevation Myocardial Infarction. Cardiovascular Therapeutics. 2025(1). 9123654–9123654.
2.
Zhang, Sijia, et al.. (2025). miR-3154: Novel Pathogenic and Therapeutic Target in Abdominal Aortic Aneurysm. Circulation Research. 137(5). 587–604.
3.
4.
Yan, Chenghui, et al.. (2025). Microplastic pollution in water and sediment in the Henan section of the Yellow River based on the MultiMP comprehensive evaluation method. Journal of Hazardous Materials. 495. 139059–139059. 4 indexed citations
5.
Song, Haixu, Xiaoxiang Tian, Dan Liu, et al.. (2024). CREG1 deficiency impaired myoblast differentiation and skeletal muscle regeneration. Journal of Cachexia Sarcopenia and Muscle. 15(2). 587–602. 10 indexed citations
6.
Liu, Yanxia, Meili Liu, Chenghui Yan, et al.. (2024). TRIM55 Aggravates Cardiomyocyte Apoptosis After Myocardial Infarction via Modulation of the Nrf2/HO-1 Pathway. JACC Basic to Translational Science. 9(9). 1104–1122. 2 indexed citations
7.
Wu, Hanlin, Jing Wang, Jia Li, et al.. (2024). Pentamethylquercetin attenuates angiotensin II-induced abdominal aortic aneurysm formation by blocking nuclear translocation of C/EBPβ at Lys253. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(5). 167224–167224. 2 indexed citations
8.
Liu, Dan, Xiaoli Cheng, Haixu Song, et al.. (2024). CREG1 attenuates doxorubicin-induced cardiotoxicity by inhibiting the ferroptosis of cardiomyocytes. Redox Biology. 75. 103293–103293. 15 indexed citations
9.
Liu, Dan, Quanyu Zhang, Xiaoxiang Tian, et al.. (2023). The CREG1-FBXO27-LAMP2 axis alleviates diabetic cardiomyopathy by promoting autophagy in cardiomyocytes. Experimental & Molecular Medicine. 55(9). 2025–2038. 22 indexed citations
10.
Li, Jiayin, et al.. (2023). MicroRNA-574–5p targeting HOXC6 expression inhibits the hepatocyte lipid uptake to alleviate non-alcoholic fatty liver disease. Experimental Cell Research. 428(1). 113631–113631. 6 indexed citations
11.
Yan, Bing, et al.. (2023). Fibroblast growth factor 21 and prognosis of patients with cardiovascular disease: A meta-analysis. Frontiers in Endocrinology. 14. 1108234–1108234. 7 indexed citations
12.
Yan, Chenghui, Yilong Wang, Can Chen, et al.. (2022). GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway. Cell Death and Disease. 13(4). 421–421. 26 indexed citations
13.
Zhang, Xiaolin, Yi Cai, Xu Su, et al.. (2022). Untargeted metabolomics identified kynurenine as a predictive prognostic biomarker in acute myocardial infarction. Frontiers in Immunology. 13. 950441–950441. 8 indexed citations
14.
Cheng, Xiaoli, et al.. (2020). Orosomucoid 1 Attenuates Doxorubicin‐Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling. BioMed Research International. 2020(1). 5923572–5923572. 17 indexed citations
15.
Lu, Qiulun, Zhonglin Xie, Chenghui Yan, et al.. (2017). SNRK (Sucrose Nonfermenting 1-Related Kinase) Promotes Angiogenesis In Vivo. Arteriosclerosis Thrombosis and Vascular Biology. 38(2). 373–385. 29 indexed citations
16.
Zheng, Wei Xing, Chenghui Yan, Xiaohu Wang, et al.. (2013). The TGFB1 Functional Polymorphism rs1800469 and Susceptibility to Atrial Fibrillation in Two Chinese Han Populations. PLoS ONE. 8(12). e83033–e83033. 10 indexed citations
17.
Zhao, Xin, Hao Tang, Yaling Han, & Chenghui Yan. (2011). The effect of dehydeocorydaline on calcium handing in hypoxia cardiomyocytes. 19(1). 75–80. 1 indexed citations
18.
Liang, Zhenyang, Xiaolin Zhang, Jing Bai, et al.. (2010). Association of interleukin-6 gene -572C/G single nucleotide polymorphism with coronary artery disease in Han population of north China.. Xiandai shengwu yixue jinzhan. 10(24). 4675–4678. 2 indexed citations
19.
Han, Yaling, et al.. (2009). A monocyte chemoattractant protein-1 gene polymorphism is not associated with coronary artery disease in a Han Chinese population. Clinica Chimica Acta. 403(1-2). 241–243. 15 indexed citations
20.
Han, Yaling, Yanping Xiao, Yanmei Qi, Jian Kang, & Chenghui Yan. (2008). [Expression of vascular smooth muscle cell markers during early stage of embryonic stem cell-derived embryoid bodies differentiation].. PubMed. 24(4). 385–90. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weibin Cai Breakdown of academic impact, for papers by Françoise Bono Breakdown of academic impact, for papers by Mary M. Kavurma Breakdown of academic impact, for papers by Patrizia Nigro Breakdown of academic impact, for papers by Sasha A. Singh Breakdown of academic impact, for papers by Lin Xu Breakdown of academic impact, for papers by Koichiro Mihara Breakdown of academic impact, for papers by Eva Bengtsson Breakdown of academic impact, for papers by Philipp Stawowy Breakdown of academic impact, for papers by Yan Ru Su
Rankless by CCL
2026